Verdi Productions "Man in Red Bandana" Documentary,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
184
Verdi Productions "Man in Red Bandana" Documentary, narrated by Gwyneth Paltrow debuts at Tribeca on April 23rd

EAST GREENWICH, RI --(Marketwired - April 19, 2017) - Investorideas.com reports that Verdi Productions announce the debut of their documentary film entitled "Man in Red Bandana" at Tribeca on Sunday, April 23rd. The film is part of a special screening and is an invitation-only event. The film will hit theaters and VOD platforms throughout the US in a limited day and date release in September 2017. This will be the third film released by Verdi Productions over the last two years, following Ten Thousand Saints , starring Ethan Hawke and Hailee Steinfeld, and Bad Hurt , starring Theo Rossi, Karen Allen, and Ashley Williams.

The film was written and directed by Matthew J. Weiss with Chad A. Verdi and Joshua Sason producing. Executive Producers are Michelle Verdi, Neil Cortel and Tom DeNucci. The film editors are Doug Forbes and Sam Eilertsen. The film is narrated by Gwyneth Paltrow with an original song performed by Lyle Lovett.

Man in Red Bandana tells the incredible story of Welles Crowther, a 24-year old civilian who gave his life saving others in the South Tower of the World Trade Center on 9/11. His heroics included carrying a woman on his shoulder down 17 flights of stairs. His bravery and courage only came to light eight months later due to an ordinary object -- a red bandana. Through interviews, archive footage, re-creations and animation, the film depicts Welles' story in an engaging and educational manner. The ending depicts the diverse ways that Welles is honored throughout the United States leading to the revelation of a secret about Welles that can only be described as beautifully inspirational.

Verdi stated, "Many of Welles' family and friends will be in attendance for this very special screening. It's truly an honor to be able to share Welles' incredible story with the world."

Verdi and Sason will donate all net profits to the Welles Remy Crowther Trust

http://www.crowthertrust.org/

Chad A. Verdi on IMDB

http://www.imdb.com/find?ref_=nv_sr_fn&q=chad+a+verdi&s=all

Man in Red Bandana Trailer

https://vimeo.com/182011815

Man in Red Bandana on IMDB

http://www.imdb.com/title/tt4687392/

Verdi Productions http://www.verdifilms.com

Verdi Productions is a fully-funded film production company located in East Greenwich, RI, with additional satellite offices in Edgartown, MA, New York City and Los Angeles. The company pursues all aspects of filmmaking -- carrying projects from concept through post-production.

Over the past 6 years, managing partner Chad A. Verdi, and his investment partners have invested over $100 million dollars into sixteen feature films. Verdi has produced four films in partnership with Emma Tillinger Koskoff and the legendary Martin Scorsese. Verdi produced Bleed For This (Miles Teller, Aaron Eckhart, Katey Sagal, Ciaran Hinds), and executive produced Silence (directed by Martin Scorsese and starring Liam Neeson, Andrew Garfield, Adam Driver), Bad Hurt (starring Theo Rossi, Karen Allen, Ashley Williams) and the documentary The 50 Year Argument (directed by Martin Scorsese and David Tedeschi).

Stay updated by visiting our Facebook page at: https://www.facebook.com/verdiproductions

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.

Chad A. Verdi - Producer of Bleed for This, Silence President, Verdi Productions Verdi Productions 214 Main Street East Greenwich, Rhode Island 02818 http://www.verdifilms.com For further information, please contact: Investorideas.com +1-800-665-0411 info@verdifilms.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 0

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 51

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 326

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 349

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 11

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 187

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 483

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 197

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading